When fragments link: a bibliometric perspective on the development of fragment-based drug discovery

Angelo K.S. Romasanta, Peter van der Sijde, Iina Hellsten, Roderick E. Hubbard, Gyorgy M. Keseru, Jacqueline van Muijlwijk-Koezen, Iwan J.P. de Esch

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated from pharmaceutical sciences, chemistry, biology, and physics, among others. To enrich our understanding of the development of the field, we used bibliometric techniques to analyze 3642 publications in FBDD, complementing accounts by key practitioners. Mapping its core papers, we found the transfer of knowledge from academia to industry. Co-authorship analysis showed that university–industry collaboration has grown over time. Moreover, we show how ideas from other scientific disciplines have been integrated into the FBDD paradigm. Keyword analysis showed that the field is organized into four interconnected practices: library design, fragment screening, computational methods, and optimization. This study highlights the importance of interactions among various individuals and institutions from diverse disciplines in newly emerging scientific fields.
Original languageEnglish
Pages (from-to)1596-1609
JournalDrug Discovery Today
Volume23
Issue number9
Early online date5 May 2018
DOIs
Publication statusPublished - Sep 2018

Fingerprint

Bibliometrics
Drug Discovery
Authorship
Pharmaceutical Chemistry
Physics
Libraries
Publications
Industry

Cite this

@article{aa16c7928ca948a3a6e0b3adfb3ad045,
title = "When fragments link: a bibliometric perspective on the development of fragment-based drug discovery",
abstract = "Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated from pharmaceutical sciences, chemistry, biology, and physics, among others. To enrich our understanding of the development of the field, we used bibliometric techniques to analyze 3642 publications in FBDD, complementing accounts by key practitioners. Mapping its core papers, we found the transfer of knowledge from academia to industry. Co-authorship analysis showed that university–industry collaboration has grown over time. Moreover, we show how ideas from other scientific disciplines have been integrated into the FBDD paradigm. Keyword analysis showed that the field is organized into four interconnected practices: library design, fragment screening, computational methods, and optimization. This study highlights the importance of interactions among various individuals and institutions from diverse disciplines in newly emerging scientific fields.",
author = "Romasanta, {Angelo K.S.} and {van der Sijde}, Peter and Iina Hellsten and Hubbard, {Roderick E.} and Keseru, {Gyorgy M.} and {van Muijlwijk-Koezen}, Jacqueline and {de Esch}, {Iwan J.P.}",
year = "2018",
month = "9",
doi = "10.1016/j.drudis.2018.05.004",
language = "English",
volume = "23",
pages = "1596--1609",
journal = "Drug Discovery Today",
issn = "1359-6446",
publisher = "Elsevier Limited",
number = "9",

}

When fragments link : a bibliometric perspective on the development of fragment-based drug discovery. / Romasanta, Angelo K.S.; van der Sijde, Peter; Hellsten, Iina; Hubbard, Roderick E.; Keseru, Gyorgy M.; van Muijlwijk-Koezen, Jacqueline; de Esch, Iwan J.P.

In: Drug Discovery Today, Vol. 23, No. 9, 09.2018, p. 1596-1609.

Research output: Contribution to JournalArticleAcademicpeer-review

TY - JOUR

T1 - When fragments link

T2 - a bibliometric perspective on the development of fragment-based drug discovery

AU - Romasanta, Angelo K.S.

AU - van der Sijde, Peter

AU - Hellsten, Iina

AU - Hubbard, Roderick E.

AU - Keseru, Gyorgy M.

AU - van Muijlwijk-Koezen, Jacqueline

AU - de Esch, Iwan J.P.

PY - 2018/9

Y1 - 2018/9

N2 - Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated from pharmaceutical sciences, chemistry, biology, and physics, among others. To enrich our understanding of the development of the field, we used bibliometric techniques to analyze 3642 publications in FBDD, complementing accounts by key practitioners. Mapping its core papers, we found the transfer of knowledge from academia to industry. Co-authorship analysis showed that university–industry collaboration has grown over time. Moreover, we show how ideas from other scientific disciplines have been integrated into the FBDD paradigm. Keyword analysis showed that the field is organized into four interconnected practices: library design, fragment screening, computational methods, and optimization. This study highlights the importance of interactions among various individuals and institutions from diverse disciplines in newly emerging scientific fields.

AB - Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated from pharmaceutical sciences, chemistry, biology, and physics, among others. To enrich our understanding of the development of the field, we used bibliometric techniques to analyze 3642 publications in FBDD, complementing accounts by key practitioners. Mapping its core papers, we found the transfer of knowledge from academia to industry. Co-authorship analysis showed that university–industry collaboration has grown over time. Moreover, we show how ideas from other scientific disciplines have been integrated into the FBDD paradigm. Keyword analysis showed that the field is organized into four interconnected practices: library design, fragment screening, computational methods, and optimization. This study highlights the importance of interactions among various individuals and institutions from diverse disciplines in newly emerging scientific fields.

UR - http://www.scopus.com/inward/record.url?scp=85047433955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047433955&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2018.05.004

DO - 10.1016/j.drudis.2018.05.004

M3 - Article

VL - 23

SP - 1596

EP - 1609

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

IS - 9

ER -